Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...

With 1,000 Canadian patients waiting for lifesaving stem ... background. People who are Black, Indigenous, Asian, Hispanic or of mixed-race heritage make up only about a third of the Canadian stem ...

The only curative treatment currently available for people with sickle cell in the UK is a donor stem cell transplant. But it is not given to many patients due to the risks involved. Casgevy is an ...

The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...

Fintel reports that on February 13, 2025, UBS initiated coverage of Jasper Therapeutics (NasdaqCM:JSPR) with a Buy recommendation. Analyst Price Forecast Suggests 1,084.43% Upside As of January 29, ...

present an important study that applied a high-resolution transposon-based barcoding system to show the clonal contribution of hematopoietic stem and ...

Marlise R. Luskin, MD, MSCE, discusses the trial of tagraxofusp in BPDCN, which showed high response rates and overall survival.

Chair Jane Bell welcomed Dr. George to the Board and said, “Greg brings not only a high conviction in Mesoblast and our therapies but additionally important operational and strategic dimensions to our ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

Manufacturing: As a result of FDA approval of RYONCIL in December 2024, the US$23.0 million provision against the value of inventory manufactured and expensed in prior periods was reversed and is now ...